List of insiders holdings for LA JOLLA PHARMACEUTICAL CO:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | BIOMARIN PHARMACEUTICAL INC 10% Owner |
2009-06-24 16:45:15 | 3,280,568 0 |
3,280,568 | Form 13D |
2 | ENGBERS WILLIAM Director |
2005-05-20 18:49:18 | 1,699,540 0 |
1,699,540 | Form 4 |
3 | TIDMARSH GEORGE F President, CEO & Secretary |
2019-04-17 17:04:23 | 1,263,897 22,000 |
1,285,897 | Form 4 |
4 | Gonzalez Alejandro 10% Owner |
2009-02-13 11:45:09 | 1,138,147 0 |
1,138,147 | Form 13G |
5 | Reinisch Richard Individual Investor |
2013-03-22 15:39:16 | 1,100,000 0 |
1,100,000 | Form 4 |
6 | ENGLE STEVEN B CEO & Chairman |
2006-02-10 13:05:47 | 685,406 0 |
685,406 | Form 5 |
7 | WELCH WILLIAM J VP Sales & Marketing |
2005-05-20 17:19:59 | 474,409 0 |
474,409 | Form 4 |
8 | Liang Bertrand C. Director |
2010-12-08 15:37:20 | 300,000 0 |
300,000 | Form 4 |
9 | MARTIN STEPHEN Director |
2010-06-02 15:06:30 | 300,000 0 |
300,000 | Form 4 |
10 | FILDES ROBERT PHD Director |
2010-06-02 15:04:44 | 300,000 0 |
300,000 | Form 4 |
11 | HEILBRUNN KENNETH R VP of Clinical Development |
2005-04-05 13:14:55 | 208,214 0 |
208,214 | Form 4 |
12 | Zarrabian Saiid Director |
2015-05-15 16:44:37 | 109,231 688 |
109,919 | Form 4 |
13 | BENNETT BRUCE K JR VP of Manufacturing |
2006-04-18 16:47:06 | 107,816 431 |
108,247 | Form 4 |
14 | REILLY TEDDI VP of Human Resources |
2006-04-18 16:47:47 | 106,385 0 |
106,385 | Form 4 |
15 | THOMPSON W LEIGH MD PHD Former Director Director |
2004-05-25 22:00:11 | 0 83,000 |
83,000 | Form 4 |
16 | Rolke James Chief Scientific Officer |
2020-06-02 16:02:20 | 81,976 0 |
81,976 | Form 4 |
17 | Chawla Lakhmir S Chief Medical Officer |
2020-09-17 16:57:20 | 73,733 0 |
73,733 | Form 4 |
18 | CAVIAR NIV EDWARD Chief Business Officer & CFO |
2009-02-03 18:04:15 | 55,000 0 |
55,000 | Form 4/A |
19 | TANSEY MICHAEL JAMES BYRON Executive VP & CMO |
2009-02-03 18:03:18 | 45,000 0 |
45,000 | Form 4/A |
20 | WISEMAN ANDREW Sen Dir Investor Relations |
2007-02-07 18:47:44 | 42,052 0 |
42,052 | Form 4 |
21 | SEIKKULA LUKE Vice President Manufacturing |
2009-02-03 18:06:56 | 35,000 0 |
35,000 | Form 4/A |
22 | CARVER JENNIFER Chief Operating Officer |
2019-03-04 17:30:59 | 14,279 0 |
14,279 | Form 4 |
23 | KOCH LISA I VP Regulatory & Project Mgmt. |
2007-02-07 18:48:40 | 12,500 0 |
12,500 | Form 4 |
24 | RINGO WILLIAM R Director |
2004-05-25 21:31:43 | 11,000 0 |
11,000 | Form 4 |
25 | Naini Nader J Director |
2007-05-24 18:24:48 | 10,000 0 |
10,000 | Form 4 |
26 | ADAMS THOMAS PHD Director |
2008-05-23 18:12:17 | 10,000 0 |
10,000 | Form 4 |
27 | YOUNG FRANK Director |
2008-05-23 16:17:03 | 10,000 0 |
10,000 | Form 4 |
28 | Wellinghoff Darryl Chief Commercial Officer |
2020-04-17 16:03:16 | 9,538 0 |
9,538 | Form 4 |
29 | MULROY DENNIS Chief Financial Officer |
2020-06-02 16:03:04 | 5,149 0 |
5,149 | Form 4 |
30 | LINNIK MATTHEW D CSO & Exec VP of Research |
2006-12-27 17:19:21 | 1,300 0 |
1,300 | Form 4 |
31 | SLOAN GAIL A Chief Financial Officer |
2011-04-21 20:13:36 | 1,120 0 |
1,120 | Form 4 |
32 | JENN PAUL VP of Product Development |
2007-01-11 19:47:37 | 526 0 |
526 | Form 4 |
33 | Gillespie Deirdre President & CEO |
2011-05-18 19:55:53 | 111.2 0 |
111.2 | Form 4 |
34 | Johnson Craig A Director |
2022-08-24 20:17:54 | 0 0 |
0 | Form 4 |
35 | Johnson Laura L. Director |
2022-08-24 20:18:06 | 0 0 |
0 | Form 4 |
36 | Hearne Michael S Chief Financial Officer |
2022-08-24 20:19:10 | 0 0 |
0 | Form 4 |
37 | Edwards Larry G. Chief Executive Officer |
2022-08-24 20:20:36 | 0 0 |
0 | Form 4 |
38 | TANG KEVIN C Director 10% Owner |
2022-08-24 20:21:25 | 0 0 |
0 | Form 4 |
39 | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
2022-08-24 16:02:16 | 0 0 |
0 | Form 4 |
40 | RAMSAY DAVID A Director |
2022-08-24 20:22:23 | 0 0 |
0 | Form 4 |
41 | Rosen Robert Director |
2022-08-24 20:27:43 | 0 0 |
0 | Form 4 |
42 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
2020-02-14 15:59:02 | 0 0 |
0 | Form 13G |
43 | SUTTER MARTIN P Director |
2009-08-07 16:48:23 | 0 0 |
0 | Form 4 |
44 | ESSEX WOODLANDS HEALTH VENTURES FUND VII LP 10% Owner |
2009-08-07 16:46:19 | 0 0 |
0 | Form 4 |
45 | ESSEX WOODLANDS HEALTH VENTURES FUND VI L P 10% Owner |
2009-08-07 16:45:52 | 0 0 |
0 | Form 4 |
46 | Elchico Josefina T VP Quality Operations |
2009-03-05 16:07:20 | 0 0 |
0 | Form 4 |
47 | SMITH CRAIG R Director |
2009-02-27 17:46:09 | 0 0 |
0 | Form 4 |
48 | Topper James N Director |
2009-02-26 18:09:40 | 0 0 |
0 | Form 4 |
49 | Frazier Healthcare V LP FHM V LLC FHM V LP 10% Owner |
2009-03-02 17:14:54 | 0 0 |
0 | Form 13D |